Characterization of tumor heterogeneity at the sequence level presents new challenges and opportunities for targeted therapies.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Evolving copy number gains promote tumor expansion and bolster mutational diversification
Nature Communications Open Access 06 March 2024
-
De novo regulation of RD3 synthesis in residual neuroblastoma cells after intensive multi-modal clinical therapy harmonizes disease evolution
Scientific Reports Open Access 13 August 2019
-
Comparison of variations detection between whole-genome amplification methods used in single-cell resequencing
GigaScience Open Access 06 August 2015
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Nowell, P.C. Science 194, 23–28 (1976).
Hou, Y. et al. Cell 148, 873–885 (2012).
Xu, X. et al. Cell 148, 886–895 (2012).
Gerlinger, M. et al. N. Engl. J. Med. 366, 883–892 (2012).
Navin, N. et al. Nature 472, 90–94 (2011).
Anderson, K. et al. Nature 469, 356–361 (2011).
Shah, S.P. et al. Nature 461, 809–813 (2009).
Yachida, S. et al. Nature 467, 1114–1117 (2010).
Campbell, P.J. et al. Nature 467, 1109–1113 (2010).
Shah, S.P. et al. Nature 10.1038/nature10933 (2012).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Caldas, C. Cancer sequencing unravels clonal evolution. Nat Biotechnol 30, 408–410 (2012). https://doi.org/10.1038/nbt.2213
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt.2213
This article is cited by
-
Evolving copy number gains promote tumor expansion and bolster mutational diversification
Nature Communications (2024)
-
De novo regulation of RD3 synthesis in residual neuroblastoma cells after intensive multi-modal clinical therapy harmonizes disease evolution
Scientific Reports (2019)
-
Acquired genetic alterations in tumor cells dictate the development of high-risk neuroblastoma and clinical outcomes
BMC Cancer (2015)
-
Comparison of variations detection between whole-genome amplification methods used in single-cell resequencing
GigaScience (2015)
-
Bone specific immunity and its impact on metastasis
BoneKEy Reports (2015)
